Triple-negative breast cancer (TNBC) is a heterogeneous BRCA subtype characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, as determined by immunohistochemical staining1. Here, PGR is linked to triple-negative breast carcinoma.